Drug Detail:Ibrexafungerp (Ibrexafungerp [ eye-brex-a-funj-erp ])
Drug Class: Miscellaneous antifungals
Ibrexafungerp Levels and Effects while Breastfeeding
Summary of Use during Lactation
No information is available on the use of ibrexafungerp during breastfeeding. The drug is over 99% protein bound, so amounts in milk are likely to be very low. If ibrexafungerp is required by the mother of an older infant, it is not a reason to discontinue breastfeeding, but until more data become available, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Clotrimazole, Fluconazole, Miconazole, Nystatin
Substance Identification
Substance Name
Ibrexafungerp
CAS Registry Number
1207753-03-4
Drug Class
Breast Feeding
Lactation
Antifungal Agents
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Drug Levels and Effects
- Substance Identification